Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Professional Support for Weight Management Programs Sometimes, your doctor might recommend a more structured weight management program
They get fired up, and emotion sells
Standard Digital 45 per month Essential digital access to quality FT journalism on any device
SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors PI: AeRang Kim, M.D., Ph.D
US$ 24.59
US$ 20.68
US$ 26.06
US$ 28.01
US$ 29.64
US$ 22.47
